Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. Its primary care products include Eliquis, Nurtec ODT/Vydura, Comirnaty, the Prevnar family, Abrysvo, FSME/IMMUN-TicoVac, Paxlovid and Lucira by Pfizer. Its specialty care products include Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo, Vyndaqel family, Genotropin, Sulperazon, Zavicefta, Medrol and Panzyga.


NYSE:PFE - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Humaniston Dec 29, 2020 10:38am
132 Views
Post# 32190950

EU TO BUY ANOTHER 100 MLNS PFE DOSES

EU TO BUY ANOTHER 100 MLNS PFE DOSESCovid live updates: EU to buy another 100 million Pfizer vaccine doses as nations ask to use more doses per vial

UPDATED TUE, DEC 29 202010:32 AM EST

CNBC.com staff
This is CNBC’s live blog covering all the latest news on the coronavirus outbreak. This blog will be updated throughout the day as the news breaks. 
The U.K. is expected to approve the coronavirus vaccine developed by AstraZeneca and the University of Oxford in the next few days. If approved this week, the AstraZeneca shot would likely be rolled out next week and would be administered alongside the Pfizer-BioNTech vaccine, which has been given to at least 600,000 people in the U.K. so far. To avoid a third wave of the outbreak, Britain must vaccinate two million people a week, according to a study by the London School of Hygiene and Tropical Medicine.
The U.S. is recording at least 180,905 new Covid-19 cases and at least 2,210 virus-related deaths each day, based on a seven-day average calculated by CNBC using Johns Hopkins University data.
The following data was compiled by Johns Hopkins University:

  • Global cases: More than 81.39 million 
  • Global deaths: At least 1.77 million
  • U.S. cases: More than 19.31 million
  • U.S. deaths: At least 335,051
7 MIN AGO
EU to buy another 100 million Pfizer vaccine doses
The European Union has agreed to buy an additional 100 million doses of the Pfizer-BioNTech Covid vaccine, the head of the European Commission announced.

The additional purchase will make for a total of 300 million doses for the 27-nation bloc.
—Sara Salinas
17 MIN AGO
EU asked to OK a sixth dose from Pfizer vaccine vials
The European Union has been asked to approve an extra dose of the Covid-19 vaccine developed by Pfizer taken from each vial, Reuters reports. The practice is allowed elsewhere and would make scarce supplies go further.
Experts and developer BioNTech say it’s possible, with the right equipment, to extract six doses of the drug from each vial. Only 5 doses are guaranteed, so that’s what the European Medicines Agency authorized, according to the Reuters report.
The long-awaited European vaccine rollout began over the weekend, though nations are struggling with limited supplies amid rising infections.
—Sara Salinas
 


<< Previous
Bullboard Posts
Next >>